Artivion | CRY - Actif À Court Terme

Prix De L'Action
25.41
Variation Quotidienne
-10.01 -28.26%
Mensuellement
-30.40%
Annuel
-12.11%
Q2 Prévisions
24.88




Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
Accuray USD 292.39M 11.22M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 357.52M 566K 2026-03
AtriCure USD 313.69M 8.82M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Inogen USD 203.72M 594K 2025-09
Integra LifeSciences USD 1.17B 12.47M 2026-03
J&J USD 59.17B 3.55B 2026-03
Mesa Laboratories USD 105.63M 8.2M 2025-12
Orthofix International USD 461.52M 44.67M 2026-03
Pfizer USD 42.82B 76M 2026-03
ResMed USD 4.06B 245.26M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Surmodics USD 75.99M 5.31M 2025-06
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
Terumo JPY 815.56B 71.48B 2025-12
Trinity Biotech USD 35.52M 2.52M 2025-09